Zevalin® (ibritumomab tiuxetan)
For further information, please see the Injectable drugs page.
Radioimmunotherapy; indicated for the treatment of relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma (NHL)
See PA form for criteria for Commercial and Medicaid
Refer to CMS local coverage determination criteria for Part B when available.